Press centre

Latest

26 Apr 2022

GARDP study reveals that babies are increasingly dying of neonatal sepsis caused by drug-resistant bacterial infections

A large study focusing on newborn babies with clinically diagnosed sepsis has revealed the impact of antibiotic resistance on neonatal sepsis, a major cause of death in newborns.

10 May 2022

GARDP North America seeks an Executive Director – United States, Remote

22 Mar 2022

GARDP welcomes funding from the Australian Government to boost its critical work to tackle drug-resistant infections

10 Mar 2022

GARDP welcomes positive results in Venatorx phase 3 clinical trial of new treatment for serious bacterial infections

8 Feb 2022

Potentially life-saving treatment is safe to use for babies with neonatal sepsis, study reveals

3 Feb 2022

GARDP calls for nominations for a new Audit Committee Member with life science background

24 Nov 2021

GARDP calls for nominations for a new Audit Committee Member with legal background

Media contacts

For media inquiries, please contact the GARDP Communications Department:

Phone: +41 22 555 19 90 | Email: communications@gardp.org

Cookie Policy

We use cookies to provide you a better experience and understand how our site is being used. To consent to the use of cookies, click ‘Accept’. Learn more about our cookie and privacy policy.